Aaron’s practice focuses on patent litigation and counseling, with an emphasis on the life sciences and biotechnology. His experience includes matters before the federal courts and the United States International Trade Commission. Aaron leverages his scientific background to assist clients with biosimilars proceedings, litigation under the Hatch-Waxman Act, and advocacy before the Food and Drug Administration.

Prior to joining the firm, Aaron was a tenured professor in Peru where he oversaw the design and construction the first genomic sequencing facility in the country. He also supervised the parallel development of a gene bank for large-scale cryogenic preservation of native genetic resources. Aaron’s doctoral research explored within-species genetic variation in the bird genus Tangara, focusing on the influence of biogeography. At the time, he was a Research Associate at the Field Museum’s Pritzker Laboratory for Molecular Systematics and Evolution.

While in Peru, Aaron obtained funding for an Illumina NextSeq 500 Genomic Sequencer from the Fondo Nacional de Ciencia y Tecnología (FONDECYT). In April 2016 he received an award for the publication of Scientific Articles from the Consejo Nacional de Ciencia y Tecnología (CONCYTEC) in Peru.

Aaron was a summer associate with Axinn in 2019. He graduated with honors from Emory University. Aaron earned his PhD and master’s degrees from the University of Chicago. There, Aaron received a Graduate Research Fellowship from the National Science Foundation for three years beginning in March 2008. He was also awarded a Hinds Fund Research Grant from the University of Chicago in June 2008. He holds a BA in Biology from Earlham College.

Professional Activities

• Connecticut Bar Association

Thought Leadership

• Chevron Deference on the Brink: Small Fish May Mean Big Changes for FDA, FDLI’s Update Magazine, Spring 2024 Issue, March 29, 2024
• FDA After Chevron, March 5, 2024
• FDA’s Califf is ‘Very Worried’ About Judges Overruling Agency Decisions, Pink Sheet, January 25, 2024
• Axinn IP Update: District of Delaware Magistrate Judge Recommends Dismissal of Claims of Induced Infringement in Skinny Label Case, June 28, 2023
• Axinn IP Update: Federal Circuit Denies Petition for Rehearing En Banc in GSK v. Teva, February 17, 2022
• Happy 10th Birthday, Intellectual Property Magazine, September 27, 2021
• Opinion: Purple Book Patent Listings Are Only a First Step, The Center for Biosimilars, May 8, 2021
• Axinn IP Update: Federal Circuit Says Functional Patent Claims Must Clear "High Hurdles", Axinn Update, February 12, 2021
• How Justice Barrett’s Confirmation Might Impact Patent Eligibility, World IP Review, December 1, 2020
• How 2 Recent Court Cases Could Impact Follow-On Biologics Strategy, Biosimilar Development, July 23, 2019

Education

• JD, with Honors ­– Emory University School of Law (2020)
• PhD, Committee on Evolutionary Biology – The University of Chicago (2014)
• MS, Committee on Evolutionary Biology – The University of Chicago (2009)
• BA – Earlham College (2007)

Admissions

• Connecticut
• U.S. District Court District of Connecticut